1. Zheng, Jing, Zhang, Yi-Wen, Pan, Zong-Fu. . [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma]. In Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 43, 685-695. doi:10.3881/j.issn.1000-503X.13271. https://pubmed.ncbi.nlm.nih.gov/34728029/
2. Lu, Xiao-Qing, Zhang, Jia-Qian, Zhang, Sheng-Xiao, Gao, Chong, Zhang, Huan-Hu. 2021. Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis. In BMC cancer, 21, 697. doi:10.1186/s12885-021-08358-7. https://pubmed.ncbi.nlm.nih.gov/34126961/
3. Wang, Xing, Yu, Jiandi, Yan, Junfeng, Peng, Kun, Zhou, Haiyong. 2022. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy. In BMC urology, 22, 37. doi:10.1186/s12894-022-00991-z. https://pubmed.ncbi.nlm.nih.gov/35305591/
4. Ding, Xiang, Fu, Qingyan, Chen, Weixing, Zhang, Sanjun, He, Linfang. 2022. Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells. In Cell biology international, 46, 840-848. doi:10.1002/cbin.11774. https://pubmed.ncbi.nlm.nih.gov/35143103/
5. Liu, Sizhe, Miao, Mingsan, Kang, Le. . Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review. In Medicine, 102, e32625. doi:10.1097/MD.0000000000032625. https://pubmed.ncbi.nlm.nih.gov/36637946/
6. Li, Qian, Tong, Dongdong, Jing, Xintao, Huang, Chen, Zhang, Mingxin. 2023. MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer. In Cancer gene therapy, 30, 727-737. doi:10.1038/s41417-022-00586-8. https://pubmed.ncbi.nlm.nih.gov/36599972/
智鼠故事 
